[Biochemical bases of Parkinson disease].
D000109:Acetylcholine / Q000378:metabolism; D000547:Amantadine / Q000627:therapeutic use; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001921:Brain / Q000378:metabolism; D004296:Dopa Decarboxylase / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D006719:Homovanillic Acid / Q000378:metabolism; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D009638:Norepinephrine / Q000378:metabolism; D010300:Parkinson Disease / Q000188:drug therapy / Q000201:enzymology / Q000378:metabolism*; D011954:Receptors, Dopamine / Q000378:metabolism; D012642:Selegiline / Q000627:therapeutic use; D012701:Serotonin / Q000378:metabolism; D013378:Substantia Nigra / Q000378:metabolism; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D011954:Receptors, Dopamine; D012642:Selegiline; D012701:Serotonin; D007980:Levodopa; D005680:gamma-Aminobutyric Acid; D000547:Amantadine; D014446:Tyrosine 3-Monooxygenase; D004296:Dopa Decarboxylase; D000109:Acetylcholine; D004298:Dopamine; D009638:Norepinephrine; D006719:Homovanillic Acid
Le basi biochimiche del morbo di Parkinson.